NCT00073515View on ClinicalTrials.gov

Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices

PHASE2CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

Not specified

Conditions
Catheters, Indwelling
Interventions
DRUG

Alfimeprase

Trial Locations (1)

Unknown

Cleveland Clinic Foundation, Cleveland

Sponsors
All Listed Sponsors
lead

ARCA Biopharma, Inc.

INDUSTRY

NCT00073515 - Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access Devices | Biotech Hunter | Biotech Hunter